The global pre-clinical imaging market size is estimated to be USD xx billion in 2021 and is expected to witness a CAGR of xx% during the forecast period. Technological developments in the area of molecular imaging is a key driver for the growth of the global pre-clinical imaging market. Additionally, growth in the number of public-private investment to support pre-clinical researches along with increase in adaptation of diagnostic imaging are some of the other drivers propelling the market growth. Nevertheless, stringent guidelines governing pre-clinical research and high cost of pre-clinical imaging treatment are expected to restrain the global market growth.

By Imaging Products

Based on imaging products, the market is segmented into optical imaging, CT imaging, multi-modal imaging, MRI imaging, PET/SPECT imaging devices, ultrasound imaging, photoacoustic (PAT) imaging, reagents, and services. In 2021, the multi-modal imaging segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to technical advancements that has been directed towards the development of combined systems that is inclusive of anatomical and molecular digital imaging systems worldwide. Reagents segment projected to grow at a profitable CAGR during the forecast period. This is attributed to these products being widely used in all imaging procedures globally.

Regional Insights

In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the presence of major players in the region, availability of trained professionals, increase in the number of preclinical projects, and accessibility of technological advanced products in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the low cost of research & development, growing government and corporate investment in healthcare sector, and less-strict supervisory guidelines are the major factors in this region.

Competitor Insights

Some of the key players in the pre-clinical imaging market are Bruker Corporation (U.S.); Siemens A.G (Germany); General Electric (GE) (U.S.); TriFoil Imaging (U.S.); PerkinElmer, Inc. (U.S.); VisualSonics Inc. (Fujifilm) (Canada); Mediso Ltd. (Hungary); MILabs B.V. (Netherlands); Agilent Technologies (U.S.); and MR Solutions (U.K.). The leading players operating in the pre-clinical imaging industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The pre-clinical imaging market report is categorized into the following segments and subsegments:

Pre-clinical Imaging Market, By Imaging Products (Revenue, USD Billion, 2021 – 2029)

• Optical Imaging
• CT Imaging
• Multi-modal Imaging
• MRI Imaging
• PET/SPECT Imaging Devices
• Ultrasound Imaging
• Photoacoustic (PAT) Imaging
• Reagents
• Services Blood Banks

Pre-clinical Imaging Market, By Region (Revenue, USD Billion, 2021 – 2029)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA

Scope of Pre-clinical Imaging Market Report:

Key Parameters	Details
Base Year	2021
Forecast Period	2022-2029
Study Coverage	Global and regional market size and revenue forecast Segment market size and revenue forecast at global, regional, and country level Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis) Conclusion and recommendations
Qualitative Analysis	Market drivers Market restraints Market opportunities Recent market trends Market challenges Porter’s Five Forces analysis PEST analysis Value-chain analysis COVID-19 impact analysis
Regional Market Scope	North America (U.S. and Canada) Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe) Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC) Latin America (Brazil, Mexico, Argentina, Rest of LATAM) MEA (South Africa, GCC, Rest of MEA)
Company Profiles	Exhaustive profiles of top 15 players 50+ other major players listing
15% Free Customization Available	You can customize the study scope to meet your exact requirement. Click here for more details